AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial

标题
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
作者
关键词
Ghrelin, Type 2 diabetes, Insulin, Body weight, Obesity, Prader-Willi syndrome, Fats, Glucose
出版物
PLoS One
Volume 13, Issue 1, Pages e0190849
出版商
Public Library of Science (PLoS)
发表日期
2018-01-11
DOI
10.1371/journal.pone.0190849

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started